Results

Total Results: 1,524 records

Showing results for "drugs".

1281. mHealth for Diabetes (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/tnd-0855-170515.pdf
      April 28, 2017 - mHealth for Diabetes i Results of Topic Selection Process & Next Steps The nominator, a managed care pharmacist, is interested in a new systematic review evaluating the effectiveness of mobile health (mHealth) technologies for diabetes. This topic met the Effective Health Care Program selection crit…

1282. mHealth for Diabetes (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0855-170515.pdf
      April 28, 2017 - mHealth for Diabetes i Results of Topic Selection Process & Next Steps The nominator, a managed care pharmacist, is interested in a new systematic review evaluating the effectiveness of mobile health (mHealth) technologies for diabetes. This topic met the Effective Health Care Program selection crit…

1283. Cad-Pci-Bypass Surveillance (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_surveillance.pdf
      May 01, 2013 - CER #9: Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Grafting for Coronary Artery Disease Original release date: October 2007 Surveillance Report: May 2013 Key Findings: - New RCT and cohort studies further delineate which patients have improved outcome…

1284. Hypertension-Pulmonary-Arterial Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
      April 01, 2013 - These new data may clarify any effect on mortality and gauge the comparative effectiveness of these drugs … Additionally, combination drug therapy (using multiple drugs with different mechanisms of action) is … In order to 5 optimize PAH care, newer information regarding the latest drugs and combination therapies … compared a single drug (monotherapy) with placebo or standard therapy and included the following drugs … Drugs did not significantly differ in their odds of causing dizziness or diarrhea.

1285. Diagnosis and Treatment of Clinical Alzheimer's-type Dementia (CATD) (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/catd-protocol-draft_0.pdf
      November 02, 2018 - pharmacological interventions, and nonprescription pharmacological interventions (e.g., over-the-counter drugs … claims abound on the internet and elsewhere about the cognitive benefits of dozens of over-the-counter drugs … Prescription Drugs Used for Treatment of CATD Cognition, Function, Quality of Life or BPSD Class of … inhibitors, NMDA antagonists, KQ 4-6: For targeting BPSD and quality of life outcomes: Prescription drugs … Since this outcome eliminated, drugs targeted to these symptoms should be eliminated.

1286. Methods Guide for Comparative Effectiveness Reviews - Expanded Guidance on Selected Quantitative Synthesis Topics (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/quantitative-synthesis-expanded-methods_methods.pdf
      March 01, 2013 - combined functional outcomes measured on different scales in placebo-controlled studies of Alzheimer’s drugs … and large referents,34 the clinical significance of the additional treatment effect of Alzheimer’s drugs … Enhanced persistence with tiotropium compared with other respiratory drugs in COPD. … Drugs Aging. 2007;24:155-67. 34. Cohen J.

1287. Untitled (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children-update_research-protocol.pdf
      December 04, 2015 - that is currently available in the United States; we will assess the evidence for all uses of these drugs … We will search for clinical study reports from the European Medicines Agency, and search Drugs@FDA for … We will revise the inclusion/exclusion form from the original review (e.g., add conditions and new drugs … However, such an approach does not allow for comparisons between drugs that may not have much direct … evidence (e.g., drug A has been compared to drug B and C, but drugs B and C have not been directly

1288. Pharmacologic Management of Acute Pain by EMS in the Prehospital Setting Protocol Amendment (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/acute-pain-ems-protocol-amendment.pdf
      January 28, 2019 - analgesics, including ketamine, nitrous oxide/oxygen, acetaminophen, and non-steroidal anti-inflammatory drugs … prehospital analgesia, issues pertaining to emergency medical services (EMS) personnel who administer the drugs … Abbreviations: KQ=key question; NSAIDs=nonsteroidal anti-inflammatory drugs; PICOTS=population, intervention

1289. Microsoft Word - 3-DKE274__ACEI-ARB-DRI__Comments_Disposition_Table-21_Jan_2011 cyk _2_.docx (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_disposition-comments.pdf
      October 07, 2011 - the Food and Drug Administration and as described in the prescribing information for the above cited drugs … Prescribing information for these drugs may be obtained from www.astrazeneca-us.com or by calling the … Recommend the following language: “When used in pregnancy during the second and third trimesters, drugs

1290. EPC-Pilot-Project-A-Dual-Approach-To-Facilitate-Health-Systems-Uptake-Of-Evidence-Synthesis-Reports-Anxiety-In-Children (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-anxiety-children_0.pdf
      October 01, 2018 - Formulary Committee Neurology and Psychiatry Task Force, responsible for making decisions on which drugs … therapy (specifically, they were asked to simulate a decision in which they are trying to choose which drugs …  Explicit description of the intervention (dosing, duration, delivery, manpower, trade names of drugs

1291. uterine-fibroids-protocol-160301 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/uterine-fibroids_research-protocol.pdf
      March 01, 2016 -  bleeding;;  In  vitro   fertilization;;  Precocious  puberty;;  Prostate  cancer   AstraZeneca   Pharmaceuticals … indications:     Endometrial  hyperplasia;;  Endometriosis;;   Menopausal  symptom   Bayer  Healthcare   Pharmaceuticals

1292. Since their introduction in 20xx, DES have been shown in clinical trials to decrease TLR (… (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
      January 01, 2010 - Since their introduction in 20xx, DES have been shown in clinical trials to decrease TLR (… The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part of AHRQ’s Effective Health Care program. It is a collaborative network of research centers that support the rapid development o…

1293. Crosscutting-Horizon-Scan-High-Impact-1312 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1312.pdf
      December 01, 2013 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … It differentiated 100% of multiple drugs and doses taken simultaneously by type and by dose.

1294. Data-Points-8 Tables1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/data-points-8_tables1.pdf
      January 01, 2009 - Medicare Parts A, B, and D Beneficiaries With Hypertension, With Use of One or More Antihypertensive Drugs … , With Hypertension and Use of One or More Antihypertensive Drugs, and Average Number of Antihypertensive … Medicare Parts A, B, and D Beneficiaries With Hypertension and Use of One or More Antihypertensive Drugs … Medicare Parts A, B, and D Beneficiaries With Hypertension and Use of One or More Antihypertensive Drugs … Medicare Parts A, B, and D Beneficiaries With Hypertension and Use of One or More Antihypretensive Drugs

1295. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
      March 10, 2010 - Each class of drugs is given own paragraph except statins and fibrates are combined. … statins with different lipid-modifying drugs are compared with ?higher-dose? statins. … richness in the potential benefits of other permutations of co-administering other lipid- modifying drugs … not meet treatment targets could benefit greatly from the co- administration of other lipid-modifying drugs … The way it is now, some outcomes are not reported for some drugs.

1296. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-liver-metastases-therapies_research-protocol.pdf
      September 27, 2012 - whereby the concentration of a drug is greatly reduced before it reaches the systemic circulation) of drugs … Chemoembolization drugs and embolic mixtures have also changed a great deal in the last ten years

1297. Disposition of Comments for Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis -- Update of a 2007 Report (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_disposition-comments.pdf
      March 01, 2012 - For drugs like etidronate and sodium fluoride that could produce abnormal bone (osteomalacia) fracture … Based on a new RCT, we have added Teriparatide to the conclusion about drugs that effectively prevent … Yet these drugs are not included in the efficacy section. Delete. … These drugs have been omitted from the evidence table as they were deleted from the report. … A review of studies examining the characteristics of the drugs was beyond the scope of this project.

1298. Systematic Review of Intermittent Inhaled Corticosteroids and of Long-acting Muscarinic Antagonists for Asthma (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-pharmacologic-treatment_research-protocol.pdf
      December 27, 2016 - Drugs 2009;69:137-150. PMID: 19228072. … Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT. 2016 10.

1299. Disposition of Comments Report for Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non-ST Elevation Myocardial Infarction (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_disposition-comments.pdf
      January 01, 2014 - Should drugs be administered right before PCI, 6 hours prior, 12 hours prior if possible? … I found the descriptions of the classes of drugs very helpful. … This is already a very large report, and delving further into the background for these drugs is out … UFH given the small number of studies with a head-to- head comparison of those drugs. … However, in KQ 1, all three drugs were compared.

1300. The Refinement of Topics for Systematic Reviews: Lessons and Recommendations From the Effective Health Care Program (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-topic-refinement_methods.pdf
      January 01, 2013 - Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) … • Include information on the FDA status, indications, and relevant warnings for drugs or devices to … • Include information on the FDA status, indications, and relevant warnings for drugs or devices to … Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) … PICO (Intervention): Corticosteroids; Synthetic disease- modifying anti- rheumatic drugs (DMARDs)